Yahoo Finance Today's Free Research Reports Coverage on Teladoc and Three More Healthcare Information Services Stocks
Stock Research Monitor: ATHN, EVH, and HQY
LONDON, UK / ACCESSWIRE / June 29, 2018 / If you want a free Stock Review on TDOC sign up now at www.wallstequities.com/registration. On Thursday, June 28, 2018, the NASDAQ Composite ended the trading session at 7,503.68, up 0.79%; the Dow Jones Industrial Average edged 0.41% higher, to finish at 24,216.05; and the S&P 500 closed at 2,716.31, slightly advancing 0.62%. Gains were broad based as seven out of nine sectors ended the day in positive. This Friday, WallStEquities.com has initiated reports coverage on the following Healthcare Information Services equities: athenahealth Inc. (NASDAQ: ATHN), Evolent Health Inc. (NYSE: EVH), HealthEquity Inc. (NASDAQ: HQY), and Teladoc Inc. (NYSE: TDOC). All you have to do is sign up today for this free limited time offer by clicking the link below.
www.wallstequities.com/registration
athenahealth
Watertown, Massachusetts headquartered athenahealth Inc. 's stock finished Thursday 's session 1.29% higher at $158.79 with a total trading volume of 255,199 shares. The Company 's shares have advanced 11.02% in the previous three months and 11.10% over the past twelve months. The stock is trading above its 50-day and 200-day moving averages by 6.20% and 16.25%, respectively. Additionally, shares of athenahealth, which together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems, have a Relative Strength Index (RSI) of 64.32. Get the full research report on ATHN for free by clicking below at:
www.wallstequities.com/registration/?symbol=ATHN
Evolent Health
On Thursday, shares in Arlington, Virginia headquartered Evolent Health Inc. recorded a trading volume of 834,585 shares. The stock ended the session 1.39% higher at $21.90. The Company 's shares have advanced 53.68% in the previous three months. The stock is trading above its 50-day and 200-day moving averages by 10.96% and 38.28%, respectively. Moreover, shares of Evolent Health, which through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the US, have an RSI of 53.00.
On June 04th, 2018, research firm Piper Jaffray initiated an 'Overweight' rating on the Company's stock, with a target price of $30 per share. Free research on EVH can be accessed at:
www.wallstequities.com/registration/?symbol=EVH
HealthEquity
Draper, Utah headquartered HealthEquity Inc. 's shares closed the day 3.83% higher at $77.05. The stock recorded a trading volume of 714,520 shares, which is above its three months average volume of 522.99 thousand shares. The Company 's shares have gained 27.27% over the previous three months and 50.58% over the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 4.56% and 33.63%, respectively. Additionally, shares of HealthEquity, which provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the US, have an RSI of 50.41. Visit WallStEquities.com now and sign up for the free research on HQY at:
www.wallstequities.com/registration/?symbol=HQY
Teladoc
Shares in Purchase, New York headquartered Teladoc Inc. finished 3.59% higher at $57.70. The stock recorded a trading volume of 1.46 million shares, which is above its three months average volume of 1.06 million shares. The Company 's shares have advanced 12.70% in the last month, 43.18% in the previous three months, and 59.61% over the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 14.26% and 46.70%, respectively. Furthermore, shares of Teladoc, which provides telehealth services worldwide, have an RSI of 56.05.
On June 05th, 2018, research firm Canaccord Genuity reiterated its ‘Buy ' rating on the Company 's stock with an increase of the target price from $47 a share to $63 a share. The free technical report on TDOC is available at:
www.wallstequities.com/registration/?symbol=TDOC
Wall St. Equities:
Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
WSE has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
https://wallstequities.com/legal-disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: Wall St. Equities
